| Literature DB >> 29163583 |
Mohammad M Arab1,2, Abbas Yadollahi1, Hamed Ahmadi3, Maliheh Eftekhari1, Masoud Maleki1.
Abstract
The efficiency of a hybrid systems method which combined artificial neural networks (ANNs) as a modeling tool and genetic algorithms (GAs) as an optimizing method for input variables used in ANN modeling was assessed. Hence, as a new technique, it was applied for the prediction and optimization of the plant hormones concentrations and combinations for in vitro proliferation of Garnem (G × N15) rootstock as a case study. Optimizing hormones combination was surveyed by modeling the effects of various concentrations of cytokinin-auxin, i.e., BAP, KIN, TDZ, IBA, and NAA combinations (inputs) on four growth parameters (outputs), i.e., micro-shoots number per explant, length of micro-shoots, developed callus weight (CW) and the quality index (QI) of plantlets. Calculation of statistical values such as R2 (coefficient of determination) related to the accuracy of ANN-GA models showed a considerably higher prediction accuracy for ANN models, i.e., micro-shoots number: R2 = 0.81, length of micro-shoots: R2 = 0.87, CW: R2 = 0.88, QI: R2 = 0.87. According to the results, among the input variables, BAP (19.3), KIN (9.64), and IBA (2.63) showed the highest values of variable sensitivity ratio for proliferation rate. The GA showed that media containing 1.02 mg/l BAP in combination with 0.098 mg/l IBA could lead to the optimal proliferation rate (10.53) for G × N15 rootstock. Another objective of the present study was to compare the performance of predicted and optimized cytokinin-auxin combination with the best optimized obtained concentrations of our other experiments. Considering three growth parameters (length of micro-shoots, micro-shoots number, and proliferation rate), the last treatment was found to be superior to the rest of treatments for G × N15 rootstock in vitro multiplication. Very little difference between the ANN predicted and experimental data confirmed high capability of ANN-GA method in predicting new optimized protocols for plant in vitro propagation.Entities:
Keywords: G × N15 rootstock; Prunus micro-propagation; artificial neural network (ANN); cytokinin–auxin combination; genetic algorithm (GA); proliferation
Year: 2017 PMID: 29163583 PMCID: PMC5672016 DOI: 10.3389/fpls.2017.01853
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Interaction of BAP and IBA different concentrations on in vitro proliferation of G × N15.
| Media | BAP (mg/l) | IBA (mg/l) | NS | LS (cm) | CW (g) | QI |
|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.33 ± 0.21 | 2.53 ± 0.06 | 0.01 ± 0.01 | 4.83 ± 0.11 |
| 2 | 0 | 0.05 | 1.33 ± 0.21 | 2.12 ± 0.05 | 0.02 ± 0.008 | 4.83 ± 0.11 |
| 3 | 0 | 0.1 | 1.67 ± 0.16 | 2.18 ± 0.06 | 0.07 ± 0.02 | 4.92 ± 0.08 |
| 4 | 0 | 0.15 | 1.67 ± 0.16 | 1.98 ± 0.03 | 0.04 ± 0.01 | 5.00 ± 0.00 |
| 5 | 0.5 | 0 | 3.17 ± 0.66 | 1.87 ± 0.03 | 0.09 ± 0.05 | 4.58 ± 0.15 |
| 6 | 0.5 | 0.05 | 3.67 ± 0.71 | 2.32 ± 0.03 | 0.10 ± 0.01 | 4.33 ± 0.11 |
| 7 | 0.5 | 0.1 | 3.33 ± 0.56 | 1.86 ± 0.04 | 0.14 ± 0.03 | 4.17 ± 0.11 |
| 8 | 0.5 | 0.15 | 3.17 ± 0.48 | 2.38 ± 0.05 | 0.19 ± 0.02 | 4.17 ± 0.11 |
| 9 | 1 | 0 | 8.33 ± 0.21 | 2.82 ± 0.03 | 0.16 ± 0.02 | 3.83 ± 0.11 |
| 10 | 1 | 0.05 | 9.00 ± 0.26 | 3.03 ± 0.04 | 0.18 ± 0.01 | 3.66 ± 0.11 |
| 11 | 1 | 0.1 | 10.67 ± 0.21 | 2.63 ± 0.02 | 0.22 ± 0.03 | 3.41 ± 0.15 |
| 12 | 1 | 0.15 | 6.67 ± 0.33 | 2.18 ± 0.07 | 0.27 ± 0.04 | 3.25 ± 0.11 |
| 13 | 1.5 | 0 | 3.67 ± 0.42 | 1.92 ± 0.03 | 0.18 ± 0.04 | 3.08 ± 0.15 |
| 14 | 1.5 | 0.05 | 3.33 ± 0.33 | 2.12 ± 0.05 | 0.21 ± 0.05 | 2.83 ± 0.11 |
| 15 | 1.5 | 0.1 | 3.83 ± 0.70 | 2.45 ± 0.03 | 0.18 ± 0.03 | 2.75 ± 0.21 |
| 16 | 1.5 | 0.15 | 2.67 ± 0.33 | 2.04 ± 0.04 | 0.27 ± 0.04 | 2.58 ± 0.15 |
| 17 | 2 | 0 | 3.00 ± 0.77 | 1.90 ± 0.03 | 0.36 ± 0.09 | 2.17 ± 0.17 |
| 18 | 2 | 0.05 | 2.33 ± 0.33 | 1.75 ± 0.03 | 0.20 ± 0.02 | 1.83 ± 0.11 |
| 19 | 2 | 0.1 | 2.33 ± 0.49 | 2.68 ± 0.04 | 0.31 ± 0.04 | 1.42 ± 0.15 |
| 20 | 2 | 0.15 | 4.00 ± 1.13 | 1.75 ± 0.04 | 0.35 ± 0.04 | 1.08 ± 0.08 |
Interaction of BAP and NAA different concentrations on in vitro proliferation of G × N15.
| Media | BAP (mg/l) | NAA (mg/l) | NS | LS (cm) | CW (g) | QI |
|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.16 ± 0.16 | 2.67 ± 0.04 | 0.00 ± 0.00 | 4.83 ± 0.11 |
| 2 | 0 | 0.05 | 1.83 ± 0.16 | 2.13 ± 0.05 | 0.01 ± 0.009 | 4.83 ± 0.11 |
| 3 | 0 | 0.1 | 1.17 ± 0.17 | 2.13 ± 0.06 | 0.02 ± 0.01 | 4.91 ± 0.08 |
| 4 | 0 | 0.15 | 1.17 ± 0.17 | 1.95 ± 0.02 | 0.06 ± 0.009 | 5.00 ± 0.00 |
| 5 | 0.5 | 0 | 2.83 ± 0.40 | 1.96 ± 0.04 | 0.07 ± 0.014 | 4.58 ± 0.15 |
| 6 | 0.5 | 0.05 | 4.17 ± 0.40 | 2.12 ± 0.05 | 0.09 ± 0.02 | 4.42 ± 0.08 |
| 7 | 0.5 | 0.1 | 4.00 ± 0.58 | 2.08 ± 0.11 | 0.11 ± 0.03 | 4.42 ± 0.11 |
| 8 | 0.5 | 0.15 | 3.33 ± 0.42 | 1.99 ± 0.08 | 0.16 ± 0.02 | 4.08 ± 0.15 |
| 9 | 1 | 0 | 6.67 ± 0.33 | 2.02 ± 0.03 | 0.15 ± 0.01 | 4.00 ± 0.00 |
| 10 | 1 | 0.05 | 7.50 ± 0.22 | 1.94 ± 0.05 | 0.19 ± 0.01 | 3.92 ± 0.08 |
| 11 | 1 | 0.1 | 8.50 ± 0.22 | 1.91 ± 0.04 | 0.23 ± 0.009 | 3.58 ± 0.15 |
| 12 | 1 | 0.15 | 6.00 ± 0.37 | 1.77 ± 0.04 | 0.26 ± 0.01 | 3.50 ± 0.00 |
| 13 | 1.5 | 0 | 3.83 ± 0.40 | 1.80 ± 0.03 | 0.21 ± 0.01 | 3.42 ± 0.08 |
| 14 | 1.5 | 0.05 | 3.67 ± 0.33 | 1.80 ± 0.04 | 0.25 ± 0.01 | 3.12 ± 0.11 |
| 15 | 1.5 | 0.1 | 3.33 ± 0.50 | 1.81 ± 0.05 | 0.28 ± 0.01 | 3.00 ± 0.13 |
| 16 | 1.5 | 0.15 | 2.83 ± 0.31 | 1.74 ± 0.04 | 0.32 ± 0.006 | 2.75 ± 0.11 |
| 17 | 2 | 0 | 2.50 ± 0.43 | 1.74 ± 0.03 | 0.24 ± 0.007 | 2.50 ± 0.13 |
| 18 | 2 | 0.05 | 2.33 ± 0.33 | 1.64 ± 0.02 | 0.27 ± 0.006 | 2.33 ± 0.11 |
| 19 | 2 | 0.1 | 2.00 ± 0.37 | 1.60 ± 0.03 | 0.33 ± 0.01 | 2.17 ± 0.11 |
| 20 | 2 | 0.15 | 2.67 ± 0.33 | 1.55 ± 0.02 | 0.35 ± 0.01 | 1.92 ± 0.08 |
Interaction of KIN and IBA different concentrations on in vitro proliferation of G × N15.
| Media | KIN (mg/l) | IBA (mg/l) | NS | LS (cm) | CW (g) | QI |
|---|---|---|---|---|---|---|
| 1 | 0 | 0.05 | 1.00 ± 0.00 | 2.16 ± 0.09 | 0.02 ± 0.005 | 4.60 ± 0.19 |
| 2 | 0 | 0.1 | 1.00 ± 0.00 | 2.04 ± 0.06 | 0.03 ± 0.003 | 4.00 ± 0.22 |
| 3 | 0 | 0.15 | 1.00 ± 0.00 | 1.98 ± 0.12 | 0.02 ± 0.003 | 4.10 ± 0.19 |
| 4 | 0.5 | 0.05 | 2.20 ± 0.20 | 1.76 ± 0.07 | 0.12 ± 0.017 | 3.60 ± 0.19 |
| 5 | 0.5 | 0.1 | 3.00 ± 0.32 | 1.62 ± 0.06 | 0.18 ± 0.019 | 3.40 ± 0.19 |
| 6 | 0.5 | 0.15 | 3.60 ± 0.24 | 1.50 ± 0.05 | 0.31 ± 0.012 | 3.10 ± 0.19 |
| 7 | 1 | 0.05 | 5.60 ± 0.40 | 1.42 ± 0.04 | 0.35 ± 0.014 | 2.90 ± 0.19 |
| 8 | 1 | 0.1 | 5.00 ± 0.32 | 1.28 ± 0.04 | 0.39 ± 0.014 | 2.7 ± 0.12 |
| 9 | 1 | 0.15 | 5.60 ± 0.51 | 1.26 ± 0.05 | 0.44 ± 0.005 | 2.30 ± 0.20 |
| 10 | 1.5 | 0.05 | 7.00 ± 0.32 | 1.34 ± 0.05 | 0.45 ± 0.015 | 2.00 ± 0.22 |
| 11 | 1.5 | 0.1 | 4.80 ± 0.37 | 1.22 ± 0.04 | 0.47 ± 0.015 | 1.90 ± 0.19 |
| 12 | 1.5 | 0.15 | 3.40 ± 0.24 | 1.08 ± 0.05 | 0.50 ± 0.10 | 1.40 ± 0.19 |
| 13 | 2 | 0.05 | 3.00 ± 0.32 | 1.18 ± 0.06 | 0.50 ± 0.021 | 2.30 ± 0.70 |
| 14 | 2 | 0.1 | 2.40 ± 0.24 | 1.08 ± 0.04 | 0.51 ± 0.027 | 2.00 ± 0.76 |
| 15 | 2 | 0.15 | 1.80 ± 0.20 | 1.08 ± 0.04 | 0.63 ± 0.017 | 1.50 ± 0.63 |
Interaction of KIN and NAA different concentrations on in vitro proliferation of G × N15.
| Media | KIN (mg/l) | NAA (mg/l) | NS | LS (cm) | CW (g) | QI |
|---|---|---|---|---|---|---|
| 1 | 0 | 0.05 | 1.00 ± 0.00 | 2.06 ± 0.13 | 0.02 ± 0.02 | 5.00 ± 0.00 |
| 2 | 0 | 0.1 | 1.00 ± 0.00 | 2.14 ± 0.17 | 0.07 ± 0.12 | 4.70 ± 0.27 |
| 3 | 0 | 0.15 | 1.00 ± 0.00 | 2.46 ± 0.11 | 0.02 ± 0.01 | 4.60 ± 0.22 |
| 4 | 0.5 | 0.05 | 3.00 ± 0.71 | 1.90 ± 0.07 | 0.07 ± 0.03 | 4.30 ± 0.27 |
| 5 | 0.5 | 0.1 | 3.60 ± 1.14 | 2.28 ± 0.08 | 0.12 ± 0.05 | 4.00 ± 0.00 |
| 6 | 0.5 | 0.15 | 4.60 ± 1.14 | 2.38 ± 0.24 | 0.17 ± 0.06 | 4.00 ± 0.00 |
| 7 | 1 | 0.05 | 5.40 ± 0.89 | 1.92 ± 0.08 | 0.16 ± 0.02 | 3.60 ± 0.22 |
| 8 | 1 | 0.1 | 6.80 ± 0.84 | 1.74 ± 0.11 | 0.22 ± 0.03 | 3.50 ± 0.00 |
| 9 | 1 | 0.15 | 7.40 ± 0.89 | 1.66 ± 0.05 | 0.27 ± 0.03 | 3.20 ± 0.27 |
| 10 | 1.5 | 0.05 | 6.40 ± 0.55 | 1.76 ± 0.11 | 0.25 ± 0.03 | 3.00 ± 0.00 |
| 11 | 1.5 | 0.1 | 9.80 ± 0.84 | 1.52 ± 0.16 | 0.30 ± 0.04 | 2.7 ± 0.27 |
| 12 | 1.5 | 0.15 | 6.20 ± 0.84 | 1.64 ± 0.13 | 0.33 ± 0.03 | 2.50 ± 0.00 |
| 13 | 2 | 0.05 | 3.80 ± 0.45 | 1.52 ± 0.08 | 0.30 ± 0.05 | 2.20 ± 0.27 |
| 14 | 2 | 0.1 | 4.80 ± 1.09 | 1.28 ± 0.08 | 0.36 ± 0.03 | 2.00 ± 0.00 |
| 15 | 2 | 0.15 | 2.80 ± 0.45 | 1.32 ± 0.08 | 0.39 ± 0.02 | 1.30 ± 0.27 |
Interaction of TDZ and IBA different concentrations on in vitro proliferation of G × N15.
| Media | TDZ (mg/l) | IBA (mg/l) | NS | LS (cm) | CW (g) | QI |
|---|---|---|---|---|---|---|
| 1 | 0 | 0.05 | 1.00 ± 0.00 | 1.96 ± 0.02 | 0.04 ± 0.007 | 3.50 ± 0.00 |
| 2 | 0 | 0.1 | 1.00 ± 0.00 | 1.82 ± 0.04 | 0.05 ± 0.003 | 3.30 ± 0.12 |
| 3 | 0 | 0.15 | 1.00 ± 0.00 | 1.66 ± 0.02 | 0.04 ± 0.004 | 3.10 ± 0.10 |
| 4 | 0.5 | 0.05 | 1.40 ± 0.24 | 1.76 ± 0.02 | 0.21 ± 0.012 | 2.90 ± 0.10 |
| 5 | 0.5 | 0.1 | 2.00 ± 0.00 | 1.60 ± 0.03 | 0.39 ± 0.013 | 2.60 ± 0.10 |
| 6 | 0.5 | 0.15 | 3.00 ± 0.00 | 1.52 ± 0.02 | 0.48 ± 0.029 | 2.50 ± 0.00 |
| 7 | 1 | 0.05 | 2.60 ± 0.40 | 1.62 ± 0.04 | 0.38 ± 0.012 | 2.30 ± 0.12 |
| 8 | 1 | 0.1 | 3.80 ± 0.73 | 1.42 ± 0.04 | 0.44 ± 0.007 | 2.00 ± 0.00 |
| 9 | 1 | 0.15 | 2.80 ± 0.37 | 1.30 ± 0.03 | 0.56 ± 0.023 | 1.90 ± 0.10 |
| 10 | 1.5 | 0.05 | 2.80 ± 0.37 | 1.42 ± 0.04 | 0.41 ± 0.017 | 1.60 ± 0.10 |
| 11 | 1.5 | 0.1 | 5.00 ± 0.00 | 1.30 ± 0.03 | 0.47 ± 0.016 | 1.50 ± 0.00 |
| 12 | 1.5 | 0.15 | 4.4 ± 0.24 | 1.18 ± 0.02 | 0.53 ± 0.026 | 1.10 ± 0.10 |
| 13 | 2 | 0.05 | 4.20 ± 0.58 | 1.32 ± 0.04 | 0.41 ± 0.013 | 1.00 ± 0.00 |
| 14 | 2 | 0.1 | 3.60 ± 0.24 | 1.10 ± 0.03 | 0.55 ± 0.020 | 0.80 ± 0.12 |
| 15 | 2 | 0.15 | 2.20 ± 0.49 | 0.84 ± 0.05 | 0.70 ± 0.022 | 0.50 ± 0.00 |
Statistics of ANN models for NS, LS, CW and QI of G × N15 (training vs. testing values).
| NS | LS | CW | QI | |||||
|---|---|---|---|---|---|---|---|---|
| Item | Training | Testing | Training | Testing | Training | Testing | Training | Testing |
| R Square | 0.85 | 0.81 | 0.88 | 0.87 | 0.86 | 0.88 | 0.87 | 0.87 |
| RMSE | 0.83 | 1.02 | 0.15 | 0.15 | 4.53 | 0.05 | 0.43 | 0.45 |
| 0.86 | 0.54 | 0.89 | 0.25 | 0.99 | 0.62 | 0.97 | 0.46 | |
Importance of hormones concentrations (mg/l) and combination according to the sensitivity analysis and optimization analysis on the developed ANN-GA model to reach maximum in vitro proliferation rate in G × N15.
| Item | Hormones concentrations (mg/l) (input variable) | Predicted proliferation rate (output variable) at optimal point | ||||
|---|---|---|---|---|---|---|
| BAP | IBA | NAA | KIN | TDZ | ||
| BAP + IBA | 1.02 | 0.098 | 0 | 0 | 0 | 10.53 |
| BAP + NAA | 0.98 | 0 | 0.1 | 0 | 0 | 7.89 |
| KIN + IBA | 0 | 0.01 | 0 | 1.46 | 0 | 6.62 |
| KIN + IBA | 0 | 0 | 0.048 | 1.53 | 0 | 9.19 |
| TDZ + IBA | 0 | 0.052 | 0 | 0 | 1.5 | 4.98 |
| VSR | 19.3 | 2.63 | 1.81 | 9.64 | 2.25 | |
| Rank | 1 | 3 | 5 | 2 | 4 | |
Importance of hormones concentrations (mg/l) and combination according to the sensitivity analysis and optimization analysis on the developed ANN-GA model to reach maximum in vitro height in G × N15.
| Item | Hormones concentrations (mg/l) (input variable) | Predicted height (output variable) at optimal point | ||||
|---|---|---|---|---|---|---|
| BAP | IBA | NAA | KIN | TDZ | ||
| BAP + IBA | 1.08 | 0.068 | 0 | 0 | 0 | 3.1 |
| BAP + NAA | 1.09 | 0 | 0.017 | 0 | 0 | 2.4 |
| KIN + IBA | 0 | 0.09 | 0 | 0.23 | 0 | 2.3 |
| KIN + IBA | 0 | 0 | 0.1 | 0.4 | 0 | 2.4 |
| TDZ + IBA | 0 | 0.02 | 0 | 0 | 0.23 | 2.3 |
| VSR | 12.9 | 4.7 | 3.1 | 6.8 | 6.4 | |
| Rank | 1 | 4 | 5 | 2 | 3 | |
Importance of hormones concentrations (mg/l) and combination according to the sensitivity analysis and optimization analysis on the developed ANN-GA model to reach minimum in vitro CW in G × N15.
| Item | Hormones concentrations (mg/l) (input variable) | Predicted callus weight (output variable) at optimal point | ||||
|---|---|---|---|---|---|---|
| BAP | IBA | NAA | KIN | TDZ | ||
| BAP + IBA | 0 | 0 | 0 | 0 | 0 | 0.007 |
| BAP + NAA | 0 | 0 | 0 | 0 | 0 | 0.007 |
| KIN + IBA | 0 | 0 | 0 | 0 | 0 | 0.007 |
| KIN + IBA | 0 | 0 | 0 | 0 | 0 | 0.007 |
| TDZ + IBA | 0 | 0 | 0 | 0 | 0 | 0.007 |
| VSR | 4 | 2.7 | 1.9 | 7.7 | 12.7 | |
| Rank | 3 | 4 | 5 | 2 | 1 | |
Importance of hormones concentrations (mg/l) and combination according to the sensitivity analysis and optimization analysis on the developed ANN-GA model to reach maximum in vitro QI in G × N15.
| Item | Hormones concentrations (mg/l) (input variable) | Predicted quality index (output variable) at optimal point | ||||
|---|---|---|---|---|---|---|
| BAP | IBA | NAA | KIN | TDZ | ||
| BAP + IBA | 0.13 | 0.14 | 0 | 0 | 0 | 5 |
| BAP + NAA | 0.17 | 0 | 0.14 | 0 | 0 | 5 |
| KIN + IBA | 0 | 0.15 | 0 | 0.65 | 0 | 5 |
| KIN + IBA | 0 | 0 | 0.13 | 0.38 | 0 | 5 |
| TDZ + IBA | 0 | 0.15 | 0 | 0 | 0.12 | 5 |
| VSR | 4.5 | 1.7 | 1.8 | 5.5 | 9.1 | |
| Rank | 3 | 5 | 4 | 2 | 1 | |
Effect of different concentrations and combinations of hormones on in vitro growth parameters.
| Hormones combination | Proliferation | LS (cm) | CW (g) | QI |
|---|---|---|---|---|
| 1 mg/l BAP + 0.1 mg/l IBA | 10.80 ± 0.37 a | 2.90 ± 0.03 a | 0.17 ± 0.008 e | 3.65 ± 0.06 d |
| 1 mg/l BAP+ 0.1 mg/l NAA | 8.60 ± 0.24 cd | 2.30 ± 0.03 c | 0.24 ± 0.021 d | 3.85 ± 0.06 cd |
| 1.5 mg/l KIN + 0.05 mg/l IBA | 7.00 ± 0.32 e | 1.90 ± 0.01 e | 0.41 ± 0.010 b | 4.20 ± 0.05 ab |
| 1.5 mg/l KIN + 0.05 mg/l NAA | 9.60 ± 0.24 abc | 2.05 ± 0.03 d | 0.32 ± 0.008 c | 3.95 ± 0.05 bcd |
| 1.5 mg/l KIN + 0.1 mg/l IBA | 5.00 ± 0.32 f | 1.60 ± 0.02 f | 0.42 ± 0.011 ab | 2.50 ± 0.08 e |
| 1.2 mg/l BAP + 0.098 mg/l IBA | 10.20 ± 0.37 ab | 2.82 ± 0.02 a | 0.19 ± 0.005 de | 3.85 ± 0.10 cd |
| 0.98 mg/l BAP + 0.1 mg/l NAA | 7.60 ± 0.24 de | 2.50 ± 0.04 b | 0.24 ± 0.006 d | 4.00 ± 0.08 bc |
| 1.46 mg/l KIN + 0.01 mg/l IBA | 6.80 ± 0.20 e | 2.36 ± 0.02 bc | 0.38 ± 0.007 b | 4.35 ± 0.06 a |
| 1.53 mg/l KIN + 0.048 mg/l NAA | 9.40 ± 0.24 bc | 2.40 ± 0.04 bc | 0.33 ± 0.009 c | 4.10 ± 0.06 abc |
| 1.5 mg/l KIN + 0.052 mg/l IBA | 4.40 ± 0.24 f | 1.84 ± 0.04 e | 0.46 ± 0.008 a | 2.35 ± 0.06 e |
| Medium | <0.001 | <0.001 | <0.001 | <0.001 |